Replies to post #1774 on Conatus Pharmaceuticals Inc. (CNAT)

[biotechexpert]

It is. What he was pointing out is that anything above 5% improvement over placebo could still lead to a phase 3 trial. ("further investigation")

[Inoviorulez]

Correct, but they are both being measured from baseline.